Comment
Author: Admin | 2025-04-28
Anticoagulants, NSAIDs, platelet inhibitors, and thrombolytic agents.indapamideibuprofen increases and indapamide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.indomethacinibuprofen and indomethacin both increase anticoagulation. Use Caution/Monitor.ibuprofen and indomethacin both increase serum potassium. Use Caution/Monitor.irbesartanirbesartan and ibuprofen both increase serum potassium. Use Caution/Monitor.ibuprofen decreases effects of irbesartan by pharmacodynamic antagonism. Use Caution/Monitor. Antihypertensive effect of angiotensin receptor blockers may be attenuated by NSAIDs; monitor renal function and blood pressure periodically.irbesartan, ibuprofen.Either increases toxicity of the other by Other (see comment). Use Caution/Monitor. Comment: May result in renal function deterioration, particularly in elderly or volume depleted individuals.isoproterenolibuprofen increases and isoproterenol decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.ketoprofenibuprofen and ketoprofen both increase anticoagulation. Use Caution/Monitor.ibuprofen and ketoprofen both increase serum potassium. Use Caution/Monitor.ketorolacibuprofen and ketorolac both increase anticoagulation. Use Caution/Monitor.ibuprofen and ketorolac both increase serum potassium. Use Caution/Monitor.ketorolac intranasalibuprofen and ketorolac intranasal both increase anticoagulation. Use Caution/Monitor.ibuprofen and ketorolac intranasal both increase serum potassium. Use Caution/Monitor.labetalollabetalol and ibuprofen both increase serum potassium. Use Caution/Monitor.ibuprofen decreases effects of labetalol by pharmacodynamic antagonism. Use Caution/Monitor. NSAIDs diminish antihypertensive effects of beta-blockers.lacosamideibuprofen increases levels of lacosamide by affecting hepatic enzyme CYP2C9/10 metabolism. Modify Therapy/Monitor Closely. Consider decreasing lacosamide dose when coadministered with strong CYP2C9 inhibitors.latanoprostlatanoprost, ibuprofen. unspecified interaction mechanism. Use Caution/Monitor. There are conflicting reports from studies of either increased or decreased IOP when ophthalmic prostaglandins are coadministered with NSAIDs (either systemic or ophthalmic).latanoprostene bunod ophthalmiclatanoprostene bunod ophthalmic, ibuprofen. unspecified interaction mechanism. Use Caution/Monitor. There are
Add Comment